If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.526%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10.00
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Nov 2022 10:37

RNS Number : 5054H
MyHealthChecked PLC
24 November 2022
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Director/PDMR Dealing

 

MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces that Nicholas Edwards, Chief Financial Officer of the Company, purchased 125,000 Ordinary Shares of 0.1p each in the Company ("Ordinary Shares") at a price of 1.849p per Ordinary share (the "Purchase"). Following the Purchase, Nicholas Edwards has a beneficial interest of 125,000 Ordinary Shares, representing 0.016 per cent. of the total issued share capital.

 

In addition, Lesley Innes, Non-Executive Director, purchased 250,000 Ordinary Shares of 0.1p each at a price of 1.835p per Ordinary Share. Following the Purchase, Lesley Innes has a beneficial interest of 250,000 Ordinary Shares, representing 0.032 per cent. of the total issued share capital.

 

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

Nicholas Edwards, Chief Financial Officer

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Anna Dunphy

Mob: +44(0)7876 741 001

 

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

 

 

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests, supported by a user-friendly digital interface..

 

MyHealthChecked is the umbrella brand of a range of at-home wellness tests that are available online, and will be viable for over-the-counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

 

Nicholas Edwards

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification/amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MyHealthChecked PLC

 

b)

 

LEI

 

 

213800RBHY6LZDG13168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification code

GB00BYZ2R301

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.849p

125,000

d)

 

Aggregated information

- Aggregated volume

N/A - Single transaction

- Price

e)

 

Date of the transaction

 

 

24 November 2022

f)

 

Place of the transaction

 

 

AIM, London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

 

Lesley Innes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification/amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MyHealthChecked PLC

 

b)

 

LEI

 

 

213800RBHY6LZDG13168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification code

GB00BYZ2R301

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.835p

250,000

d)

 

Aggregated information

- Aggregated volume

N/A - Single transaction

- Price

e)

 

Date of the transaction

 

 

24 November 2022

f)

 

Place of the transaction

 

 

AIM, London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBZLFLLFLXFBE
Date   Source Headline
11th Apr 20227:00 amRNSDirectorate Changes
25th Mar 20227:00 amRNSIssue of Equity
16th Mar 20222:05 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 20222:06 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
3rd Mar 20221:05 pmRNSDirectorate Change
28th Feb 202211:05 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
2nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSPartnership with Lloyds for COVID Antigen testing
13th Dec 20214:40 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSTrading update
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 202111:06 amRNSSecond Price Monitoring Extn
1st Dec 202111:00 amRNSPrice Monitoring Extension
29th Nov 202111:06 amRNSSecond Price Monitoring Extn
29th Nov 202111:01 amRNSPrice Monitoring Extension
26th Nov 202111:05 amRNSSecond Price Monitoring Extn
26th Nov 202111:00 amRNSPrice Monitoring Extension
25th Nov 202111:06 amRNSSecond Price Monitoring Extn
25th Nov 202111:00 amRNSPrice Monitoring Extension
24th Nov 20219:05 amRNSSecond Price Monitoring Extn
24th Nov 20219:00 amRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSLaunch of COVID-19 rapid antigen test service
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSBoard Change
29th Sep 20219:05 amRNSSecond Price Monitoring Extn
29th Sep 20219:00 amRNSPrice Monitoring Extension
29th Sep 20217:00 amRNSHalf-year Report
20th Sep 20212:01 pmRNSPrice Monitoring Extension
20th Sep 20217:00 amRNSStatement re. COVID-19 testing
17th Sep 20215:50 pmRNSStatement re. COVID-19 testing
13th Sep 20219:07 amRNSSecond Price Monitoring Extn
13th Sep 20219:03 amRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSNotice of Results & Q3 Trading Update
1st Sep 20217:00 amRNSMedical laboratory accreditation for COVID testing
26th Aug 202111:05 amRNSSecond Price Monitoring Extn
26th Aug 202111:01 amRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSStatement re. DHSC press release
30th Jul 20217:00 amRNSIssue of equity/PDMR Dealing
7th Jul 202111:06 amRNSSecond Price Monitoring Extn
7th Jul 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.